By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CMC Biologics 

22021 20th Avenue SE

Bothell  Washington  98021  U.S.A.
Phone: 425-485-1900 Fax: 425-486-0300


CMC Biologics is a global contract process development and manufacturer of biopharmaceuticals. We offer our clients a full suite of contract services from DNA to API and leverage our technical expertise to transform these services into solutions that meet our clients’ near- and long-term objectives. With cGMP compliant facilities in both the United States and Europe and a team of more than 500 dedicated employees, every project is performed with our absolute commitment to quality manufacturing and customer satisfaction.

While our efforts touch a defined part of the expansive drug development and commercialization continuum, we see ourselves as partners in our clients’ success bringing products to patients. CMC Biologics has become our clients’ manufacturing partner of choice because they trust us to make their needs and objectives our own.

Key Statistics

Ownership: Private

Web Site: CMC Biologics


Company News
CMC Biologics Enters Into Development And Manufacturing Agreement With Trellis Bioscience 7/27/2017 11:41:31 AM
CMC Biologics to Hire 100 to 150 Employees in Washington 7/7/2017 6:11:24 AM
Altor BioScience Corporation And CMC Biologics Announce Agreement For Manufacture And Validation Of Altor's IL-15 Superagonist Molecule, ALT-803, For Use In Phase III Clinical Trials 4/14/2017 7:47:24 AM
CMC Biologics Enters Into Manufacturing Agreement With CytoDyn (CYDY) 2/15/2017 8:33:22 AM
AGC Asahi Glass Signs Agreement To Acquire CMC Biologics 12/20/2016 9:14:24 AM
Through Their PROVEO Partnership, CMC Biologics And IDT Biologika Announce The Addition Of Cerbios-Pharma And Oncotec Pharma To Their Strategic Collaboration For Manufacture Of Antibody Drug Conjugates 10/13/2016 7:33:24 AM
CMC Biologics Cleared For Commercial Manufacture Of CSL Behring's FDA-Approved AFSTYLA 6/15/2016 11:08:02 AM
f-Star Announces An Agreement With CMC Biologics For Manufacture Of mAb2 Bispecific Antibodies 6/7/2016 2:40:58 PM
CMC Biologics Expands GMP Manufacturing Capacity In Europe 6/2/2016 7:29:31 AM
CMC Biologics Recognized As A Leader In Contract Development And Manufacturing By Customers And The Biopharmaceutical Industry 3/29/2016 9:08:33 AM